Barriers to Treg therapy in Europe: From production to regulation
There has been an increased interest in cell based therapies for a range of medical conditions in the last decade. This explosion in novel therapeutics research has led to the development of legislation specifically focused on cell and gene based therapies. In Europe, the European medicines agency (...
Main Authors: | Hennessy, C, Deptula, M, Hester, J, Issa, F |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Frontiers Media
2023
|
Similar Items
-
A GMP protocol for the manufacture of Tregs for clinical application
by: O'Neil, A, et al.
Published: (2022) -
Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use
by: Alzhrani, A, et al.
Published: (2020) -
SOCS2 regulates Foxp3+inducible Treg stability
by: Knosp, C, et al.
Published: (2011) -
Fueling regulation: IL-2 keeps CD4+ Treg cells fit.
by: Maloy, K, et al.
Published: (2005) -
Immunology. Feed your Tregs more fiber.
by: Bollrath, J, et al.
Published: (2013)